Intravenous Autologous Bone Marrow Mononuclear Stem Cell Therapy for Ischemic Stroke

Stroke - United States
doi 10.1161/strokeaha.114.007028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke

Stroke Research and Treatment
Neurology
2014English

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study

Stem Cells International
Cell BiologyMolecular Biology
2013English

Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model

Translational Stroke Research
NeuroscienceNeurologyCardiovascular MedicineCardiology
2016English

Intrathecal Autologous Bone Marrow Derived Mesenchymal Stem Cells for Ischemic Stroke: Short Term Safety and Efficacy Study

American Journal of Bioscience and Bioengineering
2015English

Mesenchymal Stem Cell-Based Therapy for Ischemic Stroke

Chinese Neurosurgical Journal
SurgeryNeurology
2016English

Bone Marrow Mononuclear Cells Protect Neurons and Modulate Microglia in Cell Culture Models of Ischemic Stroke

Journal of Neuroscience Research
Molecular NeuroscienceCellular
2010English

Therapy Effects of Bone Marrow Stromal Cells on Ischemic Stroke

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Stem Cell Therapy for Ischemic Stroke Using iPS Cells

Clinical Neurology
Neurology
2013English

Autologous Bone Marrow Mononuclear Cell Therapy Produces Durable Benefits in Limb Salvage at Five Years Post-Treatment

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy